Lexicon Pharmaceuticals Inc. (LXRX)

Market is closed

Insider Trading: Purchases

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Wade Officer	$2.34	10,000	$23,350.00	252,341	2023-06-20	Filing
Artal Large Shareholder, Director	$2.60	27,775,050	$72,215,130.00	78,634,381	2023-06-05	Filing
Invus Large Shareholder, Director	$2.50	147,390	$368,475.00	5,451,204	2022-08-05	Filing
Artal Large Shareholder, Director	$2.50	2,426,070	$6,065,175.00	50,859,331	2022-08-05	Filing
Artal Large Shareholder, Director	$2.50	16,173,800	$40,434,500.00	48,433,261	2022-08-01	Filing
Invus Large Shareholder, Director	$2.50	982,600	$2,456,500.00	5,303,814	2022-08-01	Filing
Debbane Director	$2.50	982,600	$2,456,500.00	5,303,814	2022-08-01	Filing
Artal Large Shareholder, Director	$3.20	10,937,500	$35,000,000.00	32,259,461	2020-12-16	Filing
Invus Large Shareholder, Director	$3.20	10,937,500	$35,000,000.00	32,259,461	2020-12-16	Filing
Coats Officer, Director	$3.10	50,000	$155,000.00	227,539	2019-09-18	Filing
Santini Officer	$3.52	2,000	$7,040.00	18,661	2019-09-18	Filing
Santini Officer	$3.23	2,500	$8,075.00	16,661	2019-09-18	Filing
Coats Officer, Director	$3.13	40,290	$126,107.70	177,539	2019-09-17	Filing
Coats Officer, Director	$3.13	277	$866.90	137,249	2019-09-17	Filing
Coats Officer, Director	$3.12	6,333	$19,758.96	136,972	2019-09-17	Filing
Coats Officer, Director	$3.12	3,000	$9,357.00	130,639	2019-09-17	Filing
Coats Officer, Director	$3.13	100	$312.50	127,639	2019-09-17	Filing
Debbane Director	$2.80	3,400	$9,520.00	313,417	2019-09-16	Filing
Debbane Director	$2.79	7,500	$20,925.00	310,017	2019-09-16	Filing
Debbane Director	$2.78	3,900	$10,842.00	302,517	2019-09-16	Filing